Guardian Wealth Advisors (North Carolina)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$417K Hold
2,733
0.03% 240
2025
Q4
$377K Hold
2,733
0.02% 259
2025
Q3
$350K Hold
2,733
0.02% 264
2025
Q2
$331K Hold
2,733
0.02% 252
2025
Q1
$305K Hold
2,733
0.02% 251
2024
Q4
$266K Hold
2,733
0.02% 265
2024
Q3
$314K Hold
2,733
0.03% 206
2024
Q2
$291K Hold
2,733
0.03% 205
2024
Q1
$264K Hold
2,733
0.03% 223
2023
Q4
$276K Sell
2,733
-105
-4% -$10.1K 0.04% 197
2023
Q3
$289K Buy
2,838
+502
+21% +$51K 0.05% 188
2023
Q2
$236K Sell
2,336
-34
-1% -$3.4K 0.04% 203
2023
Q1
$218K Buy
2,370
+34
+1% +$2.97K 0.04% 204
2022
Q4
$212K Buy
+2,336
New +$197K 0.04% 192
2022
Q3
Sell
-2,368
Closed -$200K 362
2022
Q2
$200K Buy
+2,368
New +$208K 0.04% 188

Other funds holding NVS

Guardian Wealth Advisors (North Carolina)'s NVS Position: Q1 2026 in Review

Guardian Wealth Advisors (North Carolina) held its Novartis (NVS) position steady in Q1 2026 at 2,733 shares worth $417K. The position accounts for 0.03% of the portfolio, ranked #240.

Guardian Wealth Advisors (North Carolina) first reported a position in NVS in Q2 2022 and has held it in 15 quarters since. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Guardian Wealth Advisors (North Carolina) held 2,733 shares of Novartis worth $417K as of Q1 2026.
  • Guardian Wealth Advisors (North Carolina) left its Novartis share count unchanged in Q1 2026.
  • Novartis made up 0.03% of Guardian Wealth Advisors (North Carolina)'s portfolio in Q1 2026, its #240 holding.
  • Guardian Wealth Advisors (North Carolina) first reported a position in Novartis in Q2 2022 and has held it in 15 quarters since.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 15 May 2026.